Creates provisions relating to ibogaine treatment

Summary

The bill would let Missouri award grants to in‑state entities that run FDA‑overseen ibogaine trials for opioid use disorder, other substance‑use disorders, or neurological and mental‑health conditions. It establishes an Ibogaine Study Fund and an Intellectual Property Fund, requires matching private money, and limits ibogaine prescribing to licensed physicians. The purpose is to expand treatment options for veterans and other at‑risk groups.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share